Radicava

Active Ingredient(s): Edaravone
FDA Approved: * May 5, 2017
Pharm Company: * MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA INC
Category: Neurological Disorders

Edaravone, sold as under the brand names Radicava and Radicut among others, is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).[1][2] The label carries a warning about the potential for hypersensitivity reactions to edaravone, and adverse effects include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Radicava 30 mg/100ml Intravenous Injection
NDC: 70510-2171
Labeler:
Mt Pharma America, Inc.
Radicava 60 mg/100ml Intravenous Injection
NDC: 70510-2172
Labeler:
Mitsubishi Tanabe Pharma America, Inc.